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In this issue of Immunity, a study by Luoma et al. (2013) provides structural evidence for direct interactions of
human Vd1+ T cell receptors with CD1d, capping a long trail of evidence that CD1 might be a major influence
on gd T cell biology.gd T cells have proved to be a difficult nut
to crack. Prior to the cloning of the T cell
receptor (TCR) g chain, the cells’ very ex-
istence was not anticipated, and, 30 years
later, we remain uncertain as to why they
are conserved in seemingly all higher ver-
tebrates. Is it because gd cells ‘‘see’’
things that ab T cells and B cells do not?
Although the gd TCR is not restricted to
recognizing antigenic peptides presented
by major histocompatibility complex
(MHC) molecules, it has remained unclear
whether a substantial fraction of the gd
repertoire is shaped by one or more alter-
native antigen-presenting structures.
In seeking an answer among ‘‘uncon-
ventional’’ MHC molecules, many of
which are of unknown function, a non-
peptide binding, MHC class I-related
molecule, T22, was shown to directly
bind the gd TCR of a clone, G8, and to
likewise engage 0.5% of splenic and
gut-associated murine gd T cells (Adams
et al., 2005). Given this, numerous studies
have investigated whether the remaining
gd T cells include specificities for other
members of the extended MHC family,
including CD1. Now two papers, including
one in this issue of Immunity by Luoma
et al. (2013), provide structural evidence
that human Vd1+ TCR can directly bind
CD1d-lipid complexes.In humans, CD1 exists in four cell-
surface-displayed forms (CD1a–CD1d),
but only as CD1d in mice. Like MHC,
CD1 can carry diverse cargoes, although
these are lipids rather than peptides.
CD1c recognition by a cytolytic human
gd T cell line expressing neither CD4 nor
CD8 was reported 25 years ago (see
Figure 1), but thereafter, studies linking
CD1 and gd T cells have been more spo-
radic. In 2000, CD1c-specific human Vd1
T cell lines were reported, albeit without
biochemical evidence (see Figure 1), while
in a very different context, the incidence of
myocarditis in coxsackie B virus-infected
Balb/c mice was regulated by Vg4+
T cells whose activation depended on
CD1d (Huber et al., 2006). More recently,
murine hepatic gd T cells were shown to
respond to CD1d-presenting cardiolipin,
a major phospholipid of bacterial cell
walls and of host mitochondria (Dieude´
et al., 2011). The implication from
these diverse findings of an underlying
connection between CD1 and gd T cells
was compounded by surface plasmon
resonance data showing that the TCR
from a Vg4Vd5 clone (expanded in a
transplant patient infected with CMV)
binds to the endothelial protein C receptor
(EPCR) (Willcox et al., 2012). EPCR is a
lipid-binding protein, very closely relatedto CD1, although gd TCR bindingwas lipid
independent.
Nonetheless, the association of CD1
with T cells has over the past 20 years
been dominated by the finding that a
complex of CD1d and a-galactosylcera-
mide (a-GalCer) is a common antigen for
semi-invariant, type I TCRab+ natural killer
T (iNKT) cells of humans and mice, added
to which there are non-a-GalCer-reactive,
CD1d-restricted type II NKT cells that are
more variable (Bendelac, 1995). Because
multimeric CD1d-a-GalCer complexes
proved to be powerful in identifying iNKT
cells in different scenarios, researchers
subsequently employed multimers of
CD1 complexed to other lipids, and it
was in this context that gd T cells recently
reentered the spotlight. Sulfatide is a
major glycosphingolipid component of
myelin, immune reactivity to which has
been implicated in multiple sclerosis
(MS). Unexpectedly, the most common
human CD1d-sulfatide multimer-binding
cells in the peripheral blood of healthy in-
dividuals were found to be Vd1+ gd T cells,
which are rare in the peripheral blood but
more common in cord blood and the in-
testine and which reportedly accumulate
in MS lesions (see Figure 1),
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Figure 1. Human CD1-Restricted gd T Cells
Shown is a list of all gd T cell clones, lines, and subsets reported to be reactive to CD1, illustrating the
diversity in reactivity (CD1 isoforms and lipids), VJg usage, and cytokine profiles and contrasting with
the highly skewed VDJd usage.
Lipids are as follows: PE, Phosphatidylethanolamine; PC, Phosphatidylcholine; PG, Phosphatidylglycerol;
Sulf, Sulfatide; aGC, alphagalactosyl-ceramide; n.d., not determined; *, cells did not react to aGC. TCR
genes names were all converted to the Lefranc/Forster nomenclature for consistency. Cytok, cytokine
profile (‘‘r’’ referring to a regulatory cytokine; e.g., IL-10 and/or TGF-b). Gray cells indicate parameters
that were not described in the cited articles.
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PreviewsCD1da-GalCer provided the focus for
the structural analysis by Luoma et al.
(2013). Whereas DP10.7 TCR binding to
CD1d was sulfatide dependent, the
AB18.1 TCR bound to ‘‘unloaded’’ CD1d
almost as well as to sulfatide-complexed
CD1d, evoking the cargo-free binding of
a human gd TCR to EPCR. A single-chain
version of the DP10.7 TCR was cocrys-
tallized with sulfatide-loaded CD1d,
revealing that the binding to CD1d is
exclusively d chain dependent. This is
unlike the binding of CD1d by type I and
type II NKT TCRs, yet strikingly reminis-
cent of how the G8 gd TCR binds T22
(Adams et al., 2005).
The d chain CDR3 accounted for sulfa-
tide specificity, whereas all three d CDRs
contributed to CD1d binding. Moreover,the capacity of the AB18.1 TCR to bind
unloaded CD1 could be modeled on a
closer alignment of several CDR3d resi-
dues with the a1 and a2 domains of
CD1, relative to DP10.7. These data
collectively suggest that the Vd1 chain
has a good structural fit with CD1d. Like-
wise, the contemporaneous analysis of a
Vd1 TCR (9C2) bound to CD1d-a-GalCer
(Uldrich et al., 2013) showed that CD1d
contact points were dominated by Vd1
residues, mostly within CDR1 but some
within CDR3. However, for the 9C2 TCR,
the CDR3 of TCRg contacted the lipid
cargo, and the aggregate antigen-binding
mode was reminiscent of a recently
described type II NKT TCR (Patel et al.,
2012). Despite the marked differences
in the binding of gd TCRs to CD1d-Immunity 39, Da-GalCer and CD1d-sulfatide, respec-
tively, the binding affinities were compa-
rable (105-106M range). Moreover,
several Vd1 clones recognized ‘‘un-
loaded’’ CD1d, and for most donors’ cells
a-GalCer only weakly increased CD1d
tetramer staining (Uldrich et al. 2013).
By analyzing tumor necrosis factor
production by Vd1 T cells in response to
CD1d-expressing cells loaded or not
with sulfatide, it was estimated that sulfa-
tide reactivity is shared by 30% of gut-
derived CD1d-restricted Vd1+ cells, or
4% of total Vd1+ T cells (Luoma et al.,
2013). Given the requirements for a
discrete functional response to a partic-
ular complex of CD1, the study might
have underestimated the Vd1 reactivity
to CD1d and sulfatide. Nonetheless, it is
an important addition to a series of inde-
pendent studies reporting CD1 recogni-
tion by gd T cells (Figure 1). Almost all fully
characterized CD1-reactive human gd
T cells expressed a Vd1-(Dd2)-Dd3-Jd1
chain paired to diverse g chains (Figure 1),
which is reminiscent of the pairing of an
invariant Va with more diverse b chains
in iNKT cells.
Intriguingly, most Vd1 TCRs previously
reported to be specific for the human
MHC-related stress-regulated antigen,
MICA, also comprise Vd1-(Dd2)-Dd3-Jd1,
and Luoma et al. found that a Vd1A B.3
TCR, described as being MICA specific,
could bind CD1d. Possibly some or all
human Vd1 TCR-reactivities attributed to
MICA might be CD1 reactive. Likewise,
whereas the reactivity of Vd1-Dd2-Dd3-
Jd1 gd T cells from the synovium of
Lyme arthritis patients to lipohexapeptide
reactive was independent of MHCI and
CD1a, CD1b, and CD1c, the potential
contribution of CD1dwas not investigated
and therefore cannot be discounted. A
similarly skewed VDJd usage was re-
ported for several Vd1+ clones isolated in
an unbiased fashion from human skin
and blood (Holtmeier et al., 2001).
Because human skin is rich in CD1
expression, this VDJd usage might impli-
cate a substantial CD1-reactive gd T cell
compartment in cutaneous immunology.
Moreover, the overall frequency of CD1-
reactive gd T cells might again have
been underestimated because of the
limited types of cargo-CD1 complexes
used to screen and because of selection
biases incurred when gd T cell subsets
are necessarily expanded for analysis.ecember 12, 2013 ª2013 Elsevier Inc. 995
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PreviewsThe refocusing of gd TCR diversity on a
recurrent Vd1-(Dd2)-Dd3-Jd1 rearrange-
ment whose product has a good struc-
tural fit to CD1d evokes developmental
selection events. All CD1 genes are highly
expressed in the thymus, and CD1d ex-
pressed by thymocytes (as opposed to
thymic epithelial cells) positively selects
developing iNKT cells (Bendelac, 1995).
This selection process, mediated by the
transcription factor promyelocytic leuke-
mia zinc finger (PLZF) protein, signaling
lymphocyte adaptor molecule (Slam)
receptors, and the SLAM-associated
adaptor protein (SAP), also confers on
iNKT cells their signatory rapid cytokine
responsiveness to TCR stimulation.
Possibly CD1 also selects human Vd1+
cells. Encouraging this view, a subset of
murine Vd6.3Vg1+ cells developmentally
acquires NKT-like rapid responsiveness
in a PLZF, SLAM-SAP-dependent pro-
cess. Because CD1a, CD1b, and CD1c
are absent from the mouse, studies ex-
ploring CD1-mediated selection of human
gd T cells might require the introduction of
human CD1 genes into murine fetal
thymic organ cultures in which T cell
development can be routinely assessed.
Germane to refocusing gd TCR diver-
sity, the homogeneity of the Vg5Vd1
dendritic epidermal T cell compartment
has been attributed to thymic positive se-996 Immunity 39, December 12, 2013 ª2013lection by Skint1, a member of the
extended B7 family of costimulators that
is itself ancestrally related to MHC (Lewis
et al., 2006). Within the B7 family, Skint is
most closely related to buytrophilins, in
which regard it has since been shown
that the reactivity of many peripheral
blood Vg9Vd2 cells is regulated by butyr-
ophilin 3A1 (Harly et al., 2012). In sum, the
gd TCR repertoire might be powerfully
shaped by several MHC-related mole-
cules, among which CD1 might play a
substantive role. The aggregate result
might be a unique repertoire for the
recognition of foreign antigens, path-
ogen-associated molecular patterns,
and/or self-encoded stress antigens.
Evolutionarily, it might be that overlaps
in the repertoires of TCRab+ and TCRgd+
T cells have emerged only relatively
recently. With the enormous potential of
recombinase-activating genes (RAG) 1
and 2 to generate diversity in antigen re-
ceptor proteins, the shape of T cell reper-
toires is largely determined by thymic
selection events that in the context of gd
T cells are now appropriately receiving
more attention.REFERENCES
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Salmonella bacteria often cause food-borne diseases. In this issue of Immunity, Choi et al. (2013) demon-
strate that the Salmonella Typhimurium-secreted protein tyrosine phosphatase, SptP, suppresses mast
cell degranulation, which enables bacterial dissemination.Mast cells are present at the body’s inter-
face with the environment in locations
such as the skin, gastrointestinal tract,
airway, and vasculature. Arising from
multipotent hematopoietic progenitors,
immature progenitors leave the bonemarrow and complete their development
peripherally within connective or mucosal
tissues (Okayama and Kawakami,
2006). Mast cells have been extensively
characterized as effectors of allergic
reactions (Galli and Tsai, 2012). Stimula-tion of immunoglobulin E (IgE)-sensitized
mast cells with antigen causes the release
(i.e., degranulation) of preformed granule-
associated proallergic mediators, such as
histamine, serotonin, proteases, and tu-
mor necrosis factor (TNF), within minutes
